Filing Details
- Accession Number:
- 0001209191-14-050677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-05 17:39:00
- Reporting Period:
- 2014-08-05
- Filing Date:
- 2014-08-05
- Accepted Time:
- 2014-08-05 17:39:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Avalanche Biotechnologies Inc. | AAVL | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | 777 Old Saw Mill River Road Tarrytown NY 10591 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-05 | 689,655 | $0.00 | 689,655 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-08-05 | 531,208 | $0.00 | 1,220,863 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-08-05 | 588,235 | $17.00 | 1,809,098 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-08-05 | 689,655 | $0.00 | 689,655 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-08-05 | 531,208 | $0.00 | 531,208 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Preferred Stock converted into Avalanche Biotechnologies, Inc. common stock on a one-for-one basis and had no expiration date.
- The Series B Preferred Stock converted into Avalanche Biotechnologies, Inc. common stock on a one-for-one basis and had no expiration date.
Billionaire Hedge Funds
